Gil Blum
Stock Analyst at Needham
(4.58)
# 252
Out of 4,412 analysts
216
Total ratings
54.68%
Success rate
21.74%
Average return
Main Sectors:
Top Industries:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Reiterates: Buy | $24 | $15.92 | +50.75% | 8 | Apr 12, 2024 | |
| IMAB I-Mab | Reiterates: Buy | $6 | $1.80 | +233.33% | 12 | Apr 12, 2024 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $9 | $4.00 | +125.00% | 16 | Apr 12, 2024 | |
| GTHX G1 Therapeutics | Reiterates: Buy | $12 | $3.99 | +200.75% | 12 | Apr 12, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $81 | $58.46 | +38.56% | 3 | Apr 11, 2024 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $90 | $53.91 | +66.94% | 12 | Apr 11, 2024 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $7 | $2.39 | +192.89% | 14 | Apr 11, 2024 | |
| GERN Geron | Reiterates: Buy | $5 | $3.79 | +31.93% | 14 | Apr 11, 2024 | |
| ACLX Arcellx | Reiterates: Buy | $81 | $51.92 | +56.01% | 14 | Apr 11, 2024 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $3.80 | - | 2 | Apr 11, 2024 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $31 | $12.36 | +150.81% | 14 | Apr 11, 2024 | |
| NKTX Nkarta | Reiterates: Buy | $15 | $6.87 | +118.34% | 10 | Apr 10, 2024 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $42 | $21.03 | +99.71% | 2 | Apr 10, 2024 | |
| GBIO Generation Bio Co. | Reiterates: Buy | $10 | $2.90 | +244.83% | 10 | Apr 10, 2024 | |
| MREO Mereo BioPharma Group | Reiterates: Buy | $6 | $2.74 | +118.98% | 9 | Apr 10, 2024 | |
| RCKT Rocket Pharmaceuticals | Reiterates: Buy | $53 | $21.98 | +141.13% | 12 | Apr 10, 2024 | |
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $17 | $8.12 | +109.36% | 13 | Apr 9, 2024 | |
| STTK Shattuck Labs | Reiterates: Buy | $12 | $10.59 | +13.31% | 9 | Apr 9, 2024 | |
| NXTC NextCure | Maintains: Buy | $4 | $1.35 | +196.30% | 7 | Mar 20, 2024 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $169 → $166 | $128.77 | +28.91% | 18 | Feb 29, 2024 | |
| AVRO AVROBIO | Reiterates: Buy | $6 | $1.20 | +400.00% | 4 | Mar 24, 2023 | |
| FOLD Amicus Therapeutics | Initiates: Hold | n/a | $10.28 | - | 1 | May 27, 2021 |
Celcuity
Apr 12, 2024
Reiterates: Buy
Price Target: $24
Current: $15.92
Upside: +50.75%
I-Mab
Apr 12, 2024
Reiterates: Buy
Price Target: $6
Current: $1.80
Upside: +233.33%
Autolus Therapeutics
Apr 12, 2024
Reiterates: Buy
Price Target: $9
Current: $4.00
Upside: +125.00%
G1 Therapeutics
Apr 12, 2024
Reiterates: Buy
Price Target: $12
Current: $3.99
Upside: +200.75%
Immunocore Holdings
Apr 11, 2024
Reiterates: Buy
Price Target: $81
Current: $58.46
Upside: +38.56%
CRISPR Therapeutics AG
Apr 11, 2024
Reiterates: Buy
Price Target: $90
Current: $53.91
Upside: +66.94%
Taysha Gene Therapies
Apr 11, 2024
Reiterates: Buy
Price Target: $7
Current: $2.39
Upside: +192.89%
Geron
Apr 11, 2024
Reiterates: Buy
Price Target: $5
Current: $3.79
Upside: +31.93%
Arcellx
Apr 11, 2024
Reiterates: Buy
Price Target: $81
Current: $51.92
Upside: +56.01%
Fate Therapeutics
Apr 11, 2024
Reiterates: Hold
Price Target: n/a
Current: $3.80
Upside: -
Nurix Therapeutics
Apr 11, 2024
Reiterates: Buy
Price Target: $31
Current: $12.36
Upside: +150.81%
Nkarta
Apr 10, 2024
Reiterates: Buy
Price Target: $15
Current: $6.87
Upside: +118.34%
Cartesian Therapeutics
Apr 10, 2024
Reiterates: Buy
Price Target: $42
Current: $21.03
Upside: +99.71%
Generation Bio Co.
Apr 10, 2024
Reiterates: Buy
Price Target: $10
Current: $2.90
Upside: +244.83%
Mereo BioPharma Group
Apr 10, 2024
Reiterates: Buy
Price Target: $6
Current: $2.74
Upside: +118.98%
Rocket Pharmaceuticals
Apr 10, 2024
Reiterates: Buy
Price Target: $53
Current: $21.98
Upside: +141.13%
Recursion Pharmaceuticals
Apr 9, 2024
Reiterates: Buy
Price Target: $17
Current: $8.12
Upside: +109.36%
Shattuck Labs
Apr 9, 2024
Reiterates: Buy
Price Target: $12
Current: $10.59
Upside: +13.31%
NextCure
Mar 20, 2024
Maintains: Buy
Price Target: $4
Current: $1.35
Upside: +196.30%
Sarepta Therapeutics
Feb 29, 2024
Maintains: Buy
Price Target: $169 → $166
Current: $128.77
Upside: +28.91%
AVROBIO
Mar 24, 2023
Reiterates: Buy
Price Target: $6
Current: $1.20
Upside: +400.00%
Amicus Therapeutics
May 27, 2021
Initiates: Hold
Price Target: n/a
Current: $10.28
Upside: -